Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

NCT01729338 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Velcade
DRUG: Cyclophosphamide
DRUG: Revlimid

Sponsor

Duke University

Collaborators

[object Object]
[object Object]